P450 Drug Design and targeting: Symposia 7 P450 Drug Design and targeting
Time: Wednesday, 02/July/2025: 10:00am - 12:00pm Session Chair: Dr. Irina Pikuleva, Case Western Reserve University, United States of America Session Chair: Dr. Edward Thomas Morgan, Emory University, United States of America
|
Location: Auditorium 003
199 Places
|
Session Topics: 7. Cytochrome P450 Drug Design and targeting
|
10:00am - 10:30amNon-Steroidal Inhibitors of CYP17A1 for Prostate Cancer Therapy
Tomasz M. Wróbel, Amit V. Pandey, Flemming S. Jørgensen, Fredrik Björkling, Jibira Yakubu, Therina du Toit, Katyayani Sharma, Jeremiah C. Harrington, Angelika Grudzińska, Oksana Rogova, Maria N. Rojas Velazquez
10:30am - 11:00amCYP46A1 as a Pharmacologic Target for Alzheimer’s Disease and Other Brain Disorders
Chair(s): Irina Pikuleva (Case Western Reserve University, United States of America)
Presentations of the Symposium
CYP46A1 as a Pharmacologic Target for Alzheimer’s Disease and Other Brain Disorders
Irina Pikuleva Case Western Reserve University, United States of America
11:00am - 11:15amTargeting steroidogenic P450s with natural compounds and nanoparticles for cancer and endocrine disorders
Jibira Yakubu, Evangelos Natsaridis, Isabel B. Sousa, Oya Tagit, Amit V. Pandey
11:15am - 11:30amAbiraterone-derived dual inhibitor targeting CYP17A1 and HDAC6 as a novel strategy to overcome temozolomide resistance in glioblastoma
Hong-Yi Lin, Tsung-I Hsu
11:30am - 12:00pmSelective chemical inhibition of CYP3A4 and CYP3A5
Taosheng Chen
|